Non-Invasive Cancer Diagnostics Market Report 2024: History, Forecast, and Analysis from 2017 to 2030

    The global non invasive cancer diagnostics and technologies market is segmented into type and technology. Based on type this market is further sub segmented into breast cancer, blood cancer, lung cancer and solid tumors. Breast cancer held the largest share in 2014 owing to factor such as increasing incidence of breast cancer. Moreover, rising awareness amongst people about symptoms, diagnosis and therapies about breast cancer has contributed towards the dominance of this segment. Also, government and non-government organization’s (NGO) initiatives to create awareness about breast cancer early diagnosis and treatment are also helping to grow this market. Breast cancer segment is also expected to witness lucrative growth over the coming seven years as a consequence of advancements like lumpectomy and partial mastectomy. Based on technology the market is segmented into immunochemistry, molecular diagnosis and clinical chemistry. Molecular diagnostic market held the largest share in 2014 as a consequence of various advantages associated to it. These advantages include high precision of diagnosis such as high specificity, high sensitivity, and rapid turnaround time.

    The global market for Non-Invasive Cancer Diagnostics was estimated to be worth US$ 108520 million in 2023 and is forecast to a readjusted size of US$ 146340 million by 2030 with a CAGR of 3.9% during the forecast period 2024-2030

    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Global Leading Market Research Publisher QYResearch announces the release of its latest report “Non-Invasive Cancer Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030”. Based on current situation and impact historical analysis (2019-2023) and forecast calculations (2024-2030), this report provides a comprehensive analysis of the global Non-Invasive Cancer Diagnostics market, including market size, share, demand, industry development status, and forecasts for the next few years.

The report provides advanced statistics and information on global market conditions and studies the strategic patterns adopted by renowned players across the globe. As the market is constantly changing, the report explores competition, supply and demand trends, as well as the key factors that contribute to its changing demands across many markets.

This information will help stakeholders make informed decisions and develop effective strategies for growth. The report's analysis of the restraints in the market is crucial for strategic planning as it helps stakeholders understand the challenges that could hinder growth. This information will enable stakeholders to devise effective strategies to overcome these challenges and capitalize on the opportunities presented by the growing market. Furthermore, the report incorporates the opinions of market experts to provide valuable insights into the market's dynamics. This information will help stakeholders gain a better understanding of the market and make informed decisions.

【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】

https://www.qyresearch.com/reports/2331203/non-invasive-cancer-diagnostics

Global Non-Invasive Cancer Diagnostics Market: Driven factors and Restrictions factors

The research report encompasses a comprehensive analysis of the factors that affect the growth of the market. It includes an evaluation of trends, restraints, and drivers that influence the market positively or negatively. The report also outlines the potential impact of different segments and applications on the market in the future. The information presented is based on historical milestones and current trends, providing a detailed analysis of the production volume for each type from 2019 to 2030, as well as the production volume by region during the same period.

The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.

The Non-Invasive Cancer Diagnostics market is segmented as below:

By Company

    Gen-Probe Inc

    Digene Corporation

    Quest Diagnostics Inc

    Cancer, Genetics Inc

    BIOVIEW Inc

    AVIVA Biosciences Corporation

    Laboratory Corporation of America Holdings (LabCorp)

    A&G Pharmaceutical

    Affymetrix Inc

    Precision Therapeutics

Segment by Type

    CTCs

    CTNAS

    Exosomes

Segment by Application

    Blood

    Urine

    Saliva

Each chapter of the report provides detailed information for readers to further understand the Non-Invasive Cancer Diagnostics market:

Chapter 1: Non-Invasive Cancer Diagnostics Market Product Definition, Product Types, Sales Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2019 to 2024.

Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Household Hazardous Waste Disposal, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Non-Invasive Cancer Diagnostics industry.

Chapter 3: Non-Invasive Cancer Diagnostics Market Historical (2019-2023) and forecast (2024-2030) sales and revenue analysis of Non-Invasive Cancer Diagnostics in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.

Chapter 4: Non-Invasive Cancer Diagnostics Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2019 to 2024.

Chapter 5 to 9: Non-Invasive Cancer Diagnostics Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.

Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Non-Invasive Cancer Diagnostics introduction, etc. Non-Invasive Cancer Diagnostics Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.

Chapter 11: Industry Chain, including raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.

Chapter 12: Market Channel, Distributors and Customers are listed.

Chapter 13: QYResearch’s Conclusions of Non-Invasive Cancer Diagnostics market based on comprehensive survey.

Chapter 14: Methodology and Data Sources.

Table of Contents

1 Non-Invasive Cancer Diagnostics Market Overview

1.1Non-Invasive Cancer Diagnostics Product Overview

1.2 Non-Invasive Cancer Diagnostics Market by Type

1.3 Global Non-Invasive Cancer Diagnostics Market Size by Type

1.3.1 Global Non-Invasive Cancer Diagnostics Market Size Overview by Type (2019-2030)

1.3.2 Global Non-Invasive Cancer Diagnostics Historic Market Size Review by Type (2019-2024)

1.3.3 Global Non-Invasive Cancer Diagnostics Forecasted Market Size by Type (2025-2030)

1.4 Key Regions Market Size by Type

1.4.1 North America Non-Invasive Cancer Diagnostics Sales Breakdown by Type (2019-2024)

1.4.2 Europe Non-Invasive Cancer Diagnostics Sales Breakdown by Type (2019-2024)

1.4.3 Asia-Pacific Non-Invasive Cancer Diagnostics Sales Breakdown by Type (2019-2024)

1.4.4 Latin America Non-Invasive Cancer Diagnostics Sales Breakdown by Type (2019-2024)

1.4.5 Middle East and Africa Non-Invasive Cancer Diagnostics Sales Breakdown by Type (2019-2024)

2 Non-Invasive Cancer Diagnostics Market Competition by Company

2.1 Global Top Players by Non-Invasive Cancer Diagnostics Sales (2019-2024)

2.2 Global Top Players by Non-Invasive Cancer Diagnostics Revenue (2019-2024)

2.3 Global Top Players by Non-Invasive Cancer Diagnostics Price (2019-2024)

2.4 Global Top Manufacturers Non-Invasive Cancer Diagnostics Manufacturing Base Distribution, Sales Area, Product Type 

2.5 Non-Invasive Cancer Diagnostics Market Competitive Situation and Trends

2.5.1 Non-Invasive Cancer Diagnostics Market Concentration Rate (2019-2024)

2.5.2 Global 5 and 10 Largest Manufacturers by Non-Invasive Cancer Diagnostics Sales and Revenue in 2023

2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Cancer Diagnostics as of 2023)

2.7 Date of Key Manufacturers Enter into Non-Invasive Cancer Diagnostics Market

2.8 Key Manufacturers Non-Invasive Cancer Diagnostics Product Offered

2.9 Mergers & Acquisitions, Expansion  

...

Overall, this report strives to provide you with the insights and information you need to make informed business decisions and stay ahead of the competition.

To contact us and get this report: https://www.qyresearch.com/contact-us

About Us：

QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 16 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.

Contact Us:

If you have any queries regarding this report or if you would like further information, please contact us:

QY Research Inc.

Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States

E-mail: global@qyresearch.com

Tel: 001-626-842-1666(US) 0086-133 1872 9947(CN)

EN: https://www.qyresearch.com

JP: https://www.qyresearch.co.jp